XT
PLSE icon

XTX Topco’s Pulse Biosciences PLSE Stock Holding History

XTX Topco’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$515K Buy
+23,841
New +$440K 0.01% 2024
2025
Q3 		– Sell
-30,886
Closed -$466K – 3115
2025
Q2 		$466K Buy
+30,886
New +$512K 0.02% 1149

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

XTX Topco's PLSE Position: Q1 2026 in Review

XTX Topco opened a new position in Pulse Biosciences (PLSE) in Q1 2026: 23,841 shares worth $515K. The stake represents 0.01% of the portfolio and ranks #2024 among its holdings. This is a return to the name: XTX Topco previously reported a position in PLSE as recently as Q2 2025.

XTX Topco first reported a position in PLSE in Q2 2025 and has held it in 2 quarters since. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • XTX Topco held 23,841 shares of Pulse Biosciences worth $515K as of Q1 2026.
  • Pulse Biosciences was a new XTX Topco position in Q1 2026.
  • Pulse Biosciences made up 0.01% of XTX Topco's portfolio in Q1 2026, its #2024 holding.
  • XTX Topco first reported a position in Pulse Biosciences in Q2 2025 and has held it in 2 quarters since.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.